Hepatitis C treatment is not reaching some at-risk populations
Two recent studies from researchers at WashU Medicine reveal that two vulnerable populations — children and recently pregnant women — face disparities in access to treatment for hepatitis C infection, putting them at risk of long-term health problems.
WashU molecular biologists identify multifunctional virus-sensing protein
WashU Medicine researchers led by Siyuan Ding identified an immune-system protein in human cells that has the unusual capacity to respond to both DNA and RNA from pathogens, which may have implications for developing vaccines.
Arthur L. Prensky, professor emeritus of neurology, 94
Arthur L. Prensky, MD, a professor emeritus of neurology at WashU Medicine, died June 16 after a short illness. He was 94. Prensky was a world authority in metabolic disorders, headache and neurodevelopment.
WashU Medicine develops new postbaccalaureate training program
WashU Medicine faculty members received funding from the National Institutes of Health (NIH) to develop the Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases, a two-year mentored research experience.
Early intervention changes trajectory for depressed preschoolers
A specialized approach to treating childhood depression developed by WashU Medicine researchers leads to long-term remission and other benefits, according to a new study.
Region’s first patient receives sickle cell gene therapy
The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.
Ornitz receives NIH grant to study lung development
The National Institutes of Health (NIH) has awarded David M. Ornitz, MD, PhD, of WashU Medicine, $740,000 annually for four years to support research aimed at understanding respiratory complications associated with premature birth.
Strategy to prevent age-related macular degeneration identified
Fixing problems with cholesterol metabolism might help slow or prevent age-related macular degeneration, a leading cause of blindness in older adults, a new WashU Medicine study in mice has shown.
Harris selected for William T. Grant Scholar Class of 2030
Occupational therapy faculty member Kelly Harris, at WashU Medicine, will receive a $425,000 award to develop and test a technology-enabled care coordination service model to support Black youth with asthma.
AI-based brain-mapping software receives FDA market authorization
The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.
View More Stories